Yesterday saw the launch in Madrid of a new NanoMed Spain publication, ‘Hoja por la Innovación en Nanomedicina en España’ (White Paper on Innovation in Nanomedicine in Spain), which diagnoses the country’s R&D&I capacities in the field so far and presents the potential opportunities, challenges and recommendations for the future.
IBEC group leader Ángel Raya is quoted in articles in online newspapers Público and Materia this week, giving his expert opinion about some recent research in Japan. The scientists in … Read more
IBEC now has its very own YouTube channel, where viewers can watch a host of videos related to the institute and aimed at a variety of audiences.
At the end of September representatives from IBEC, which coordinates and manages the Connect-EU Nanobio+Nanomed group, participated in the Connect-EU conference at Barcelona’s World Trade Centre.
Senior researcher Eduard Torrents appears several times in the July edition of the newspaper of the Associació Catalana de Fibrosi Quística, Per a Vèncer la Fibrosi Quística.
This month, the three candidates selected by the Scientific Advisory Board for IBEC’s new Tenure Track scheme started in their new capacity as Junior Group Leaders.
The IBEC-coordinated European project MySpine, which reached its midpoint at the end of August, received a positive appraisal at its first Annual Review in Brussels in June.
An IBEC researcher has collaborated on a paper published in Nature Nanotechnology that outlines an effective new way to characterize and improve nanoparticle catalysts, which play essential roles in biomedicine, industry and everyday life by affecting the rate at which chemical reactions take place.Nanoparticle catalysts are used in making polymers and biofuels, synthesising new drugs, pollution control devices and fuel cell technology, and both characterising them and finding more effective ones is vital.
IBEC group leader José Antonio del Río contributed to an Expansión article from August about funding for research, in particular neuroscience, for which 2012 was a “Year of” in Spain.
IBEC researchers have stuck tissue engineering gold with the creation of a new ‘smart’ biomaterial that triggers angiogenesis by providing the biochemical and mechanical cues needed for the process to begin.Researchers in Josep Planell’s Biomaterials for Regenerative Therapies group, in a paper led by Elisabeth Engel, reveal their calcium phosphate glass/PLA composite that itself promotes the mobilization and differentiation of endothelial progenitor cells – those that become the cells making up the lining of blood vessels.
“In regenerative medicine, successful tissue repair hinges on being able to recreate the right environment, so that the biomaterial not only acts as a scaffold for the new tissue but also contributes to the activation of the regeneration process,” explains Elizabeth.